• Innovating for patients with Chronic Inflammatory Demyelinating Polyneuropathy - New innovative treatments and emerging approaches

    This EAN webinar summary details advancements in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) treatment. Experts discuss unmet needs, emerging biomarkers like periaxin and NfL, and novel therapies including FcRN inhibitors and complement inhibitors. The session highlights the shift towards targeted treatments and improved monitoring strategies for this complex neurological condition.

    Thomas Harbo,Pietro Doneddu,Roberto Bellanti ,Luis Querol Speaker: Thomas Harbo,Pietro Doneddu,Roberto Bellanti ,Luis Querol

    FundamentalLevel: Fundamental

    Topics in this course:

    CIDP Neurology MedicalResearch Biomarkers NewTreatments